Biora Therapeutics Inc.

NASDAQ: PROG · Real-Time Price · USD
0.88
-0.04 (-3.96%)
At close: May 09, 2022, 6:00 AM

Biora Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
1.25M
Cost of Revenue
n/a
Gross Profit
1.25M
Operating Income
-234.9M
Interest Income
n/a
Pretax Income
-178.64M
Net Income
-178.52M
Selling & General & Admin
73.3M
Research & Development
45.78M
Other Expenses
n/a
Operating Expenses
119.08M
Interest Expense
12.64M
Selling & Marketing Expenses
4.76M
Cost & Expenses
119.08M
Income Tax Expense
-119K
Shares Outstanding (Basic)
27.51M
Shares Outstanding (Diluted)
27.51M
EPS (Basic)
-6.49
EPS (Diluted)
-6.49
EBITDA
-233.46M
EBIT
-166M
Depreciation & Amortization
1.44M